(COP) ConocoPhillips - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US20825C1045
Stock: Crude Oil, Natural Gas, LNG, Bitumen
Total Rating 58
Risk 87
Buy Signal -0.24
| Risk 5d forecast | |
|---|---|
| Volatility | 28.3% |
| Relative Tail Risk | -1.90% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.75 |
| Alpha | 17.07 |
| Character TTM | |
|---|---|
| Beta | 0.497 |
| Beta Downside | 0.806 |
| Drawdowns 3y | |
|---|---|
| Max DD | 36.52% |
| CAGR/Max DD | 0.32 |
EPS (Earnings per Share)
Revenue
Description: COP ConocoPhillips March 04, 2026
ConocoPhillips (COP) is an independent exploration and production (E&P) company. E&P companies focus on finding and extracting hydrocarbons, rather than refining or retailing them.
The companys operations span crude oil, natural gas, LNG, and natural gas liquids across five geographic segments: Alaska, Lower 48 (contiguous US), Canada, Europe/Middle East/North Africa, and Asia Pacific. This diversified portfolio includes unconventional plays, conventional assets, and oil sands.
ConocoPhillips has a global presence, operating in numerous countries including the United States, Canada, the UK, and China. Consider exploring ValueRay for further in-depth analysis of COPs operational efficiency and financial performance.
Headlines to watch out for
- Global crude oil prices dictate exploration and production revenue
- Natural gas demand and pricing impact LNG profitability
- Regulatory changes in carbon emissions increase operating costs
- Geopolitical instability threatens international production and transport
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 7.97b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 7.23 > 1.0 |
| NWC/Revenue: 6.06% < 20% (prev 6.45%; Δ -0.39% < -1%) |
| CFO/TA 0.16 > 3% & CFO 19.80b > Net Income 7.97b |
| Net Debt (16.95b) to EBITDA (25.02b): 0.68 < 3 |
| Current Ratio: 1.30 > 1.5 & < 3 |
| Outstanding Shares: last quarter (1.20b) vs 12m ago 1.33% < -2% |
| Gross Margin: 24.82% > 18% (prev 0.29%; Δ 2.45k% > 0.5%) |
| Asset Turnover: 48.04% > 50% (prev 44.48%; Δ 3.56% > 0%) |
| Interest Coverage Ratio: 11.73 > 6 (EBITDA TTM 25.02b / Interest Expense TTM 1.14b) |
Altman Z'' 3.92
| A: 0.03 (Total Current Assets 15.53b - Total Current Liabilities 11.97b) / Total Assets 121.94b |
| B: 0.56 (Retained Earnings 68.86b / Total Assets 121.94b) |
| C: 0.11 (EBIT TTM 13.36b / Avg Total Assets 122.36b) |
| D: 1.10 (Book Value of Equity 62.98b / Total Liabilities 57.45b) |
| Altman-Z'' Score: 3.92 = AA |
Beneish M -2.99
| DSRI: 0.81 (Receivables 5.81b/6.70b, Revenue 58.78b/54.61b) |
| GMI: 1.18 (GM 24.82% / 29.35%) |
| AQI: 1.13 (AQ_t 0.11 / AQ_t-1 0.10) |
| SGI: 1.08 (Revenue 58.78b / 54.61b) |
| TATA: -0.10 (NI 7.97b - CFO 19.80b) / TA 121.94b) |
| Beneish M-Score: -2.99 (Cap -4..+1) = A |
What is the price of COP shares?
As of March 17, 2026, the stock is trading at USD 121.32 with a total of 7,555,788 shares traded.
Over the past week, the price has changed by +3.67%, over one month by +12.40%, over three months by +34.70% and over the past year by +26.28%.
Over the past week, the price has changed by +3.67%, over one month by +12.40%, over three months by +34.70% and over the past year by +26.28%.
Is COP a buy, sell or hold?
ConocoPhillips has received a consensus analysts rating of 4.37.
Therefore, it is recommended to buy COP.
- StrongBuy: 14
- Buy: 13
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the COP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 118.5 | -2.3% |
| Analysts Target Price | 118.5 | -2.3% |
COP Fundamental Data Overview March 14, 2026
P/E Trailing = 19.1953
P/E Forward = 23.1481
P/S = 2.4717
P/B = 2.2795
P/EG = 2.9914
Revenue TTM = 58.78b USD
EBIT TTM = 13.36b USD
EBITDA TTM = 25.02b USD
Long Term Debt = 22.42b USD (from longTermDebt, last quarter)
Short Term Debt = 1.02b USD (from shortTermDebt, last quarter)
Debt = 23.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.95b USD (from netDebt column, last quarter)
Enterprise Value = 165.94b USD (148.99b + Debt 23.44b - CCE 6.50b)
Interest Coverage Ratio = 11.73 (Ebit TTM 13.36b / Interest Expense TTM 1.14b)
EV/FCF = 9.89x (Enterprise Value 165.94b / FCF TTM 16.77b)
FCF Yield = 10.11% (FCF TTM 16.77b / Enterprise Value 165.94b)
FCF Margin = 28.54% (FCF TTM 16.77b / Revenue TTM 58.78b)
Net Margin = 13.56% (Net Income TTM 7.97b / Revenue TTM 58.78b)
Gross Margin = 24.82% ((Revenue TTM 58.78b - Cost of Revenue TTM 44.19b) / Revenue TTM)
Gross Margin QoQ = 19.64% (prev 24.12%)
Tobins Q-Ratio = 1.36 (Enterprise Value 165.94b / Total Assets 121.94b)
Interest Expense / Debt = 1.24% (Interest Expense 290.0m / Debt 23.44b)
Taxrate = 35.77% (803.0m / 2.25b)
NOPAT = 8.58b (EBIT 13.36b * (1 - 35.77%))
Current Ratio = 1.30 (Total Current Assets 15.53b / Total Current Liabilities 11.97b)
Debt / Equity = 0.36 (Debt 23.44b / totalStockholderEquity, last quarter 64.49b)
Debt / EBITDA = 0.68 (Net Debt 16.95b / EBITDA 25.02b)
Debt / FCF = 1.01 (Net Debt 16.95b / FCF TTM 16.77b)
Total Stockholder Equity = 65.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.52% (Net Income 7.97b / Total Assets 121.94b)
RoE = 12.25% (Net Income TTM 7.97b / Total Stockholder Equity 65.06b)
RoCE = 15.27% (EBIT 13.36b / Capital Employed (Equity 65.06b + L.T.Debt 22.42b))
RoIC = 9.71% (NOPAT 8.58b / Invested Capital 88.41b)
WACC = 6.80% (E(148.99b)/V(172.43b) * Re(7.75%) + D(23.44b)/V(172.43b) * Rd(1.24%) * (1-Tc(0.36)))
Discount Rate = 7.75% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.28%
[DCF] Terminal Value 81.39% ; FCFF base≈13.27b ; Y1≈12.02b ; Y5≈10.45b
[DCF] Fair Price = 185.4 (EV 243.51b - Net Debt 16.95b = Equity 226.56b / Shares 1.22b; r=6.80% [WACC]; 5y FCF grow -11.66% → 2.90% )
EPS Correlation: -67.57 | EPS CAGR: -26.70% | SUE: -0.80 | # QB: 0
Revenue Correlation: -62.27 | Revenue CAGR: -7.97% | SUE: -0.41 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.17 | Chg7d=+0.059 | Chg30d=+0.098 | Revisions Net=-4 | Analysts=16
EPS current Year (2026-12-31): EPS=5.11 | Chg7d=+0.361 | Chg30d=+0.438 | Revisions Net=-3 | Growth EPS=-17.0% | Growth Revenue=-6.5%
EPS next Year (2027-12-31): EPS=6.81 | Chg7d=+0.000 | Chg30d=-0.188 | Revisions Net=-5 | Growth EPS=+33.2% | Growth Revenue=+5.5%
[Analyst] Revisions Ratio: -0.67 (1 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.7% (Discount Rate 7.9% - Earnings Yield 5.2%)
[Growth] Growth Spread = -7.3% (Analyst -4.6% - Implied 2.7%)
P/E Forward = 23.1481
P/S = 2.4717
P/B = 2.2795
P/EG = 2.9914
Revenue TTM = 58.78b USD
EBIT TTM = 13.36b USD
EBITDA TTM = 25.02b USD
Long Term Debt = 22.42b USD (from longTermDebt, last quarter)
Short Term Debt = 1.02b USD (from shortTermDebt, last quarter)
Debt = 23.44b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.95b USD (from netDebt column, last quarter)
Enterprise Value = 165.94b USD (148.99b + Debt 23.44b - CCE 6.50b)
Interest Coverage Ratio = 11.73 (Ebit TTM 13.36b / Interest Expense TTM 1.14b)
EV/FCF = 9.89x (Enterprise Value 165.94b / FCF TTM 16.77b)
FCF Yield = 10.11% (FCF TTM 16.77b / Enterprise Value 165.94b)
FCF Margin = 28.54% (FCF TTM 16.77b / Revenue TTM 58.78b)
Net Margin = 13.56% (Net Income TTM 7.97b / Revenue TTM 58.78b)
Gross Margin = 24.82% ((Revenue TTM 58.78b - Cost of Revenue TTM 44.19b) / Revenue TTM)
Gross Margin QoQ = 19.64% (prev 24.12%)
Tobins Q-Ratio = 1.36 (Enterprise Value 165.94b / Total Assets 121.94b)
Interest Expense / Debt = 1.24% (Interest Expense 290.0m / Debt 23.44b)
Taxrate = 35.77% (803.0m / 2.25b)
NOPAT = 8.58b (EBIT 13.36b * (1 - 35.77%))
Current Ratio = 1.30 (Total Current Assets 15.53b / Total Current Liabilities 11.97b)
Debt / Equity = 0.36 (Debt 23.44b / totalStockholderEquity, last quarter 64.49b)
Debt / EBITDA = 0.68 (Net Debt 16.95b / EBITDA 25.02b)
Debt / FCF = 1.01 (Net Debt 16.95b / FCF TTM 16.77b)
Total Stockholder Equity = 65.06b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.52% (Net Income 7.97b / Total Assets 121.94b)
RoE = 12.25% (Net Income TTM 7.97b / Total Stockholder Equity 65.06b)
RoCE = 15.27% (EBIT 13.36b / Capital Employed (Equity 65.06b + L.T.Debt 22.42b))
RoIC = 9.71% (NOPAT 8.58b / Invested Capital 88.41b)
WACC = 6.80% (E(148.99b)/V(172.43b) * Re(7.75%) + D(23.44b)/V(172.43b) * Rd(1.24%) * (1-Tc(0.36)))
Discount Rate = 7.75% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.28%
[DCF] Terminal Value 81.39% ; FCFF base≈13.27b ; Y1≈12.02b ; Y5≈10.45b
[DCF] Fair Price = 185.4 (EV 243.51b - Net Debt 16.95b = Equity 226.56b / Shares 1.22b; r=6.80% [WACC]; 5y FCF grow -11.66% → 2.90% )
EPS Correlation: -67.57 | EPS CAGR: -26.70% | SUE: -0.80 | # QB: 0
Revenue Correlation: -62.27 | Revenue CAGR: -7.97% | SUE: -0.41 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.17 | Chg7d=+0.059 | Chg30d=+0.098 | Revisions Net=-4 | Analysts=16
EPS current Year (2026-12-31): EPS=5.11 | Chg7d=+0.361 | Chg30d=+0.438 | Revisions Net=-3 | Growth EPS=-17.0% | Growth Revenue=-6.5%
EPS next Year (2027-12-31): EPS=6.81 | Chg7d=+0.000 | Chg30d=-0.188 | Revisions Net=-5 | Growth EPS=+33.2% | Growth Revenue=+5.5%
[Analyst] Revisions Ratio: -0.67 (1 Up / 5 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.7% (Discount Rate 7.9% - Earnings Yield 5.2%)
[Growth] Growth Spread = -7.3% (Analyst -4.6% - Implied 2.7%)